Navigation Links
David W. Keiser to Retire as President of Alexion
Date:11/11/2008

number of countries," said Leonard Bell, M.D., Chief Executive Officer of Alexion and principal founder of the Company. "Under David's leadership, we initiated the development of our world-class teams in the U.S. and Europe, and laid a strong foundation for market entry in Asia and the Pacific, the Middle East and Latin America. We are deeply grateful to his numerous, durable contributions to Alexion, and to the people and processes he has put in place to ensure our ongoing success in coming years."

"I feel privileged to have been a part of what we have accomplished here at Alexion," said Mr. Keiser. "Our scientists are among the very few in the industry to have produced a major, life-changing biopharmaceutical product, and I am pleased to have had a role in bringing the benefits of Soliris to large numbers of patients worldwide. As I leave the day-to-day operations of the Company, I am gratified by the breadth and depth of Alexion executives who are in place and continue to passionately drive to fulfill our global commitments to patients."

In addition to his work at Alexion, Mr. Keiser has been active in various industry organizations and community activities and he will pursue these and other personal interests in retirement.

About Alexion

Alexion Pharmaceuticals, Inc. is a biopharmaceutical company working to develop and deliver life-changing drug therapies for patients with serious and life-threatening medical conditions. The Company is engaged in the discovery, development and commercialization of therapeutic products aimed at treating patients with a wide array of severe disease states, including hematologic diseases, cancer and autoimmune disorders. In March 2007, the FDA granted marketing approval for the Company's first product, Soliris for all patients with PNH. In June 2007, the European Commission granted marketing approval for Soliris in the European Union for all patients with PNH. The Company is evaluating other potential i
'/>"/>

SOURCE Alexion Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. St. Davids HealthCare Launches The TIA Center for Stroke Prevention at St. Davids Medical Center
2. Ortiz to Host Celebrity Golf Tournament to Benefit The David Ortiz Childrens Fund
3. Aflac Celebrates With Petersons Harley Davidson of Miami as 100,000th Online Billing Customer
4. Sunrise Senior Living Appoints Glyn Aeppel and David Fuente to its Board
5. Texas Cardiac Arrhythmia Institute at St. Davids Medical Center First in the Nation to Use a New Generation of Medical Robots for Complex Electrophysiology Mapping Procedures
6. Anpath Group, Inc. Announces Appointments of David V. Gilroy and Paul A. Boyer to Board of Directors
7. David B. Samadi, MD, Demonstrates Robotic Prostate Surgery During Live Webcast, August 13, 2008
8. Los Angeles Jewish Home Selects Community Volunteer David Swartz as its Board of Directors Chair
9. American Biosurgical Adds David Brazeal, CPA as Chief Financial Officer
10. Portable Endoscopic Company Announces Hiring of David Guy as COO/President
11. SFMS David Perlman Award For Excellence in Medical/Health Reporting Recognizes Local Reporters
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/13/2014)... July 13, 2014 Fuel additives are ... gasoline, diesel, jet fuel, kerosene, and so on, in ... responsible for reducing the corrosion effects caused by fuels ... added to any fuel, provide economies of scale in ... escalate the overall cost of the fuel products. , ...
(Date:7/13/2014)... July 13, 2014 MarketsandMarkets recently ... [3D Modeling; 3D Scanning; 3D rendering; Layout and ... Analysis (2013 - 2018)”, which analyzes and studies ... North America, Western Europe, Eastern Europe, Middle East ... also draws the competitive landscape of the 3D ...
(Date:7/13/2014)... HealthDay Reporter FRIDAY, July 11, ... for people with diabetes is being developed to measure sugar ... report. Scientists at Brown University in Providence, R.I., created ... uses light, metal and a special enzyme that changes color ... have to prick their fingers to draw blood to check ...
(Date:7/13/2014)... 2014 Athletes with a certain genetic ... concussions, according to research presented today at the American ... Meeting. The research marks the first of its kind ... known physical events that occur after a head injury. ... allele in the (GT)n genotype were four times more ...
(Date:7/13/2014)... (PRWEB) July 13, 2014 Recently, ... retailer, has unveiled its new range of gorgeous ... current market, the demand for elegant Quinceanera outfits ... more beautiful items. All the company’s newly released ... trends. They are all elegant and vivid. ...
Breaking Medicine News(10 mins):Health News:North America Fuel Additives Market is Expected to Reach $8,100 Million by 2017 - New Report by MicroMarket Monitor 2Health News:North America Fuel Additives Market is Expected to Reach $8,100 Million by 2017 - New Report by MicroMarket Monitor 3Health News:North America Fuel Additives Market is Expected to Reach $8,100 Million by 2017 - New Report by MicroMarket Monitor 4Health News:3D Imaging Market Worth $9.82 Billion By 2018 - Report by MarketsandMarkets 2Health News:3D Imaging Market Worth $9.82 Billion By 2018 - Report by MarketsandMarkets 3Health News:3D Imaging Market Worth $9.82 Billion By 2018 - Report by MarketsandMarkets 4Health News:Saliva Test Might Someday Replace Needle Prick for Diabetics 2Health News:Saliva Test Might Someday Replace Needle Prick for Diabetics 3Health News:Genetic Factors May Be Responsible for Slowing Concussion Recovery in Athletes 2Health News:2014QuinceaneraDresses.com Releases Its New Quinceanera Dresses 2
... and Crest/Oral-B Survey Unveiled at ... 2008 The American Dental,Association (ADA(R)), in collaboration with Crest(R) and ... care., Here is a sneak peek at the key ... of one,s mouth, teeth and gums is ...
... 2008/2009 survey of more than 5,500 benefit plans found 68.3 percent of ... increasing the employee portion of the premium. , ... Kansas City, KS ... containment and cost reduction measures to combat rising health care costs. The ...
... test to identify those most at risk from hair loss is now ... ... (PRWEB) October 17, 2008 -- A groundbreaking genetic test to identify those ... for both men and women. , , ,Currently only available at ...
... Year 2020, Food Companies Will Be Expected to Cede ... Oct. 16 Today,s consumers want to have a,greater ... the year,2020, consumers around the globe expect the way ... to a recent study of consumers in five,countries., ...
... Consumers, FALLS CHURCH, Va., Oct. 16 ... of digestive health issue (*see reference,below). The issue ... in,which prebiotics and probiotics could benefit them. For ... for prebiotics and,probiotics by working with a truly ...
... Oct. 16 Americans United for Life,(AUL) today filed ... Ohio,s regulation of the deadly abortion drug, RU-486., ... proven track,record of ruining and even ending women,s lives. ... of this drug. Ohio,s statute is a,step in the ...
Cached Medicine News:Health News:New National Public Opinion Survey Reveals Important Findings on Oral Health Care Perceptions 2Health News:New National Public Opinion Survey Reveals Important Findings on Oral Health Care Perceptions 3Health News:Employers' Methods for Containing and Reducing Costs Vary By Region 2Health News:Employers' Methods for Containing and Reducing Costs Vary By Region 3Health News:Breakthrough Baldness Genetic Test 2Health News:New Study Reveals Consumers Want Greater Say in Key Food Issues 2Health News:New Study Reveals Consumers Want Greater Say in Key Food Issues 3Health News:New Study Reveals Consumers Want Greater Say in Key Food Issues 4Health News:New Study Reveals Consumers Want Greater Say in Key Food Issues 5Health News:MyHealthGate, Inc. Joins With LiveActive Chewy Granola Bars to Raise Digestive Health Awareness 2Health News:Ohio's Regulation of RU-486 Clear and Constitutional, Should Be Upheld Argues AUL in Brief Filed Before Ohio Supreme Court 2
(Date:7/10/2014)... Pa. , July 10, 2014 ... Moberg Research,s (Moberg) medical device manufacturing facility. Rep. ... Moberg,s advanced neurological monitors facilitate cutting-edge research in ... Rep. Kennedy and mental health advocate, Garen ... organization dedicated to fostering fundamental changes that will ...
(Date:7/10/2014)... , July 10, 2014  Decision Resources Group ... infectious disease (ID) specialists are willing to prescribe ... (oritavancin) for use as OPAT, approximately two-thirds of ... agents to their hospital inpatients. However, our findings ... patients are initiated on OPAT following hospital discharge, ...
(Date:1/15/2014)... , Jan. 15, 2014 Sono-Tek Corporation (OTC BB: ... ended November 30, 2013, compared to sales of $2,202,000 for ... Once again, this quarter has also shown growth over the ... first quarter of this fiscal year. Markets that experienced sales ...
Breaking Medicine Technology:Representative Patrick Kennedy visits Moberg's medical device facility to discuss improvement in brain injury care 2Long-Acting Antibiotics Offering Once-Weekly Dosing Will See Favorable Uptake and Use as Outpatient Parenteral Antimicrobial Therapy (OPAT) 2Long-Acting Antibiotics Offering Once-Weekly Dosing Will See Favorable Uptake and Use as Outpatient Parenteral Antimicrobial Therapy (OPAT) 3Sono-Tek Announces Third Quarter Results 2Sono-Tek Announces Third Quarter Results 3Sono-Tek Announces Third Quarter Results 4
... Inc. (Nasdaq: MSON ), a developer of minimally invasive ... the ablation of tumors and worldwide for other acute health ... year ended June 30, 2009. , The Company also reported ... payment of $3.5 million was received on April 7, 2009 ...
... , SAN MATEO, Calif., Oct. 1 Corthera Inc. ... (FDA) has granted Fast Track designation to relaxin, the ... failure (AHF). The Fast Track program facilitates the development ... treat serious or life-threatening conditions and that demonstrate the ...
Cached Medicine Technology:Misonix Reports Fourth Quarter and Fiscal Year 2009 Financial Results 2Misonix Reports Fourth Quarter and Fiscal Year 2009 Financial Results 3Misonix Reports Fourth Quarter and Fiscal Year 2009 Financial Results 4Misonix Reports Fourth Quarter and Fiscal Year 2009 Financial Results 5Misonix Reports Fourth Quarter and Fiscal Year 2009 Financial Results 6Misonix Reports Fourth Quarter and Fiscal Year 2009 Financial Results 7Misonix Reports Fourth Quarter and Fiscal Year 2009 Financial Results 8Misonix Reports Fourth Quarter and Fiscal Year 2009 Financial Results 9Misonix Reports Fourth Quarter and Fiscal Year 2009 Financial Results 10Corthera's Relaxin Receives FDA Fast Track Designation for the Treatment of Acute Heart Failure 2Corthera's Relaxin Receives FDA Fast Track Designation for the Treatment of Acute Heart Failure 3
... Aplicare's Saturated Swabsticks are packaged ... Each 4 inch Swabstick is saturated ... solution. Each package is terminally sterilized, ... the patient. Povidone Iodine Scrub is ...
... 70% alcohol and 10% povidone iodine ... forming a barrier on the skin. ... for the povidone iodine, giving persistent ... with catheter related infections for up ...
... Aplicare's Saturated Swabsticks are ... single-use foil-laminated pouches. Each ... saturated with precisely the ... Each package is terminally ...
Triad Plus PVP-I Prep Solution has broad-spectrum germicidal action. Povidone Iodine Solution using an innovative one-piece screw cap, Triad Plus bottles are designed specifically to meet the needs o...
Medicine Products: